Why the study?
Does a perindopril-based blood pressure lowering regimen reduce the risk of recurrent stroke in patients with prior stroke or TIA, with and without diabetes?
Does a perindopril-based blood pressure lowering regimen reduce the risk of recurrent stroke in patients with prior stroke or TIA, with and without diabetes?
A perindopril-based blood pressure lowering regimen significantly reduces the risk of recurrent stroke in patients with prior cerebrovascular disease, with comparable proportional benefits regardless of diabetes status.
No takes yet. Share an insight, caveat, or question.
Supports perindopril-based BP lowering for secondary stroke prevention irrespective of diabetes; extends RCT evidence of consistent proportional benefit across subgroups.
Berthet et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: